Anebulo Pharmaceuticals, Inc.

NasdaqCM:ANEB Stock Report

Market Cap: US$59.6m

Anebulo Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Richie Cunningham

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure2yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Feb 18
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Jul 03
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 07
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Nov 19
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Anebulo Pharmaceuticals to launch private investment in public equity financing

Sep 26

Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03

Sep 09

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 28
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 15
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Nov 04
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Anebulo Pharmaceuticals reports FQ3 results

Jun 21

CEO

Richie Cunningham (52 yo)

less than a year

Tenure

Mr. Richard Anthony Cunningham, also known as Richie, is Chief Executive Officer and Director of Anebulo Pharmaceuticals, Inc. since October 2023. He served as Chief Executive Officer and Director at Tyme...


Leadership Team

NamePositionTenureCompensationOwnership
Joseph Lawler
Founder & Chairman4.1yrsUS$11.00k46.27%
$ 27.6m
Kenneth Cundy
Chief Scientific Officer2yrsUS$495.63k0%
$ 0
Richard Cunningham
CEO & Directorless than a yearno datano data
Daniel George
Principal Accounting Officerless than a yearno datano data
Scott Anderson
Head of Investor Relations & Public Affairs2.3yrsno datano data

2.0yrs

Average Tenure

52.5yo

Average Age

Experienced Management: ANEB's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Joseph Lawler
Founder & Chairman4.1yrsUS$11.00k46.27%
$ 27.6m
Richard Cunningham
CEO & Directorless than a yearno datano data
Bimal Shah
Independent Directorless than a yearno datano data
Kenneth Lin
Lead Independent Director3.3yrsUS$1.00k0%
$ 0
Areta Kupchyk
Independent Director3.1yrsUS$11.00k0%
$ 0
Jason Aryeh
Independent Director3.2yrsUS$21.00k0%
$ 0
Nathaniel Calloway
Independent Director1.6yrsUS$79.75kno data
Aron English
Independent Director3.9yrsUS$1.00k17.95%
$ 10.7m
Andrew Monte
Member of Scientific Advisory Board3.3yrsno datano data
Arjun Chanmugam
Member of Scientific Advisory Board3.3yrsno datano data

3.2yrs

Average Tenure

51yo

Average Age

Experienced Board: ANEB's board of directors are considered experienced (3.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.